Cancer Biotherapeutics
MOC Mobile Banner  

Participant List


Director Technology & Information Management, Ablynx

Senior Research Associate, Ablynx

Senior Scientist, Adaptimmune

Senior Scientist, Adaptimmune

CSO & Co-Founder, Aduro Biotech Europe

Business Development Manager, Affymetrix eBioscience

Coordination Manager, Ajinomoto Omnichem

Customer Solutions Science Manager, Albumedix

Director Business Development, Albumedix

Scientific Manager, Albumedix

Principal Scientist, Alligator Bioscience

Senior Scientist, Almac Sciences

Associate Scientist, Amgen Research Munich

Scientific Director Pharmacology, Amgen Research Munich

CEO, AmpTec


VP Molecular Biology, Apogenix

Scientist, Aquila BioMedical

CTO, Avacta Life Sciences

Business Manager, AXENIS

Scientist, Bayer HealthCare

Senior Scientist, Bayer HealthCare

Senior R&D Manager, BD Technologies

Director Product Discovery, Bellicum Pharmaceuticals

Business Development Manager, Biognosys

CSO, BioInvent

Senior Scientist, Bioven

CEO, BliNK Biomedical

Lab Head, Boehringer Ingelheim

Chief Drug Dev Scientist, Cancer Research UK

Director, Copenhagen University Hospital Herlev

Scientist, Crescendo Biologics

Team Leader, Crescendo Biologics

Project Leader, Center of Immunology Pierre Fabre

Scientist, Dana Farber Cancer Institute

Professor, ETH Zurich

QC Manager, F Hoffmann La Roche

CEO, F star

Head, Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori

Assistant Professor, Fundacao para a Faculdade de Ciencias e Tecnologia da UNL

Associate Professor, Fundacao para a Faculdade de Ciencias e Tecnologia da UNL

Editor, Future Science

Research & Development, GLYCOTOPE

CTO, Immune Targeting Systems

Head, Immunocore

Research Associate, Immunocore

Scientist, Immunocore

Senior Scientist, Immunocore

Team Leader, Immunocore

CSO, Innate Pharma

Engineer, Innate Pharma

Manager, Innate Pharma

Scientist, Institute of Molecular Biotechnology


CEO & Founder, IONTAS

Associate Director, Jackson Lab

Business Unit Manager, Jackson Lab

Information Scientist, Jackson Lab

Director Research & Tumor Immunology, Jounce Therapeutics

VP ImmunoOncology, Kymab


Medical University of Graz

Senior Scientist, MedImmune

Biomarker & Protein Specialist, Merck Millipore

Regional Sales Manager Northern Europe, Merck Millipore

Group Manager, Merck Serono Inter-Lab

Executive Director, Merck Sharp & Dohme

CSO, Merus

Medical Director, MHRA

Associate Director, MorphoSys

Scientist, MorphoSys

Managing Partner, MPM Capital

Associate Project Manager, Mycenax Biotech


Staff Scientist, NIH NCI

CSO, NovImmune

Head of Research, NovImmune

Business Account Manager, Oncodesign

Scientist, Oxford BioMedica UK

Principal Scientist, Pfizer Global R&D Groton Labs

Pieris Pharmaceuticals

Graduate Student, Plymouth University

Strategic Collaborations Manager, Promega


Head of Cell Biology, Roche Glycart

Cell Biology Group, Roche Innovation Center Zurich

Director, Simon Bennett Associates

Senior Research Fellow Medicine, Southampton General Hospital

Student, Suranaree University of Technology

President & CEO, Taris Biomedical

VP, Taris Biomedical

Director, Technical University Braunschweig

VP Immunology Research, UCB Celltech

PostDoc, Universit├Ąt Stuttgart

Professor, Universit├Ąt Stuttgart

Clinical Senior Lecturer, University College London

Group Lead, University College London

Professor, University College London

Senior Lecturer, University College London

Student, University College London

Molecular Biologist, University Complutense de Madrid

Project Leader, University Hospital Basel

Professor, University Hospital Zurich

Senior Research Fellow, University of Birmingham

Professor & Deputy Dean, University of Gdansk

Scientist, University of Gdansk

Professor, University of Genoa

Professor, University Of Limoges

Scientist, University of Milan

Professor, University of Perugia

CSO, Virttu Biologics

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Save the Date!
20-24 March 2017

Download Event Brochure

Premier Sponsors

Jackson Laboratory

View All Sponsors

View Media Partners



"Some of the most promising emergent biopharmaceuticals for cancer therapy include agents capable of selective homing to the tumor environment, as well as drugs capable of selective activation of the immune system against malignant cells."

Dario Neri, Ph.D., Swiss Federal Institute of Technology

"You have put together an amazing meeting."

Sergio A. Quezada, Ph.D., UCL Cancer Institute